Search for: "State v. Price"
Results 781 - 800
of 13,182
Sorted by Relevance
|
Sort by Date
6 May 2010, 5:16 am
Price v. [read post]
10 Jul 2019, 8:22 pm
Then, quoting Standard Oil v. [read post]
14 Jan 2011, 12:21 pm
(See Price v. [read post]
16 Jul 2007, 4:57 pm
Co. v. [read post]
21 Dec 2009, 1:06 pm
United States v. [read post]
19 Jan 2011, 10:46 am
Naylor Group Inc. v Ellis-Don Construction Ltd., [1996] OJ No 3247, 31 CLR (2d) 195 (ON Gen Div), revd [1999] 119 OAC 182 (ONCA), vard 2001 SCC 58, [2001] 2 SCR 943, online: LexUM http://scc.lexum.org/en/2001/2001scc58/2001scc58.html This is not a tender dispute between an owner and a bidder, but between a general contractor and a subcontractor whose prices were used to secure a low bid. [read post]
28 Feb 2011, 8:27 am
Supreme Court, urging the Court to hear and overturn Arkansas Carpenters Health and Welfare Fund v. [read post]
18 Oct 2018, 2:29 pm
Supp. 2d 109, 115 (D.D.C. 2004) (citing United States v. [read post]
16 Feb 2021, 1:14 pm
The Court relied on Barnes v. [read post]
5 Feb 2014, 6:46 am
Contents include:Leon E Trakman, The Status of Investor - State Arbitration: Resolving Investment Disputes under the Transpacific Partnership AgreementBroussolle Damien, Service, Trade in Services and Trade of Services IndustriesLucas Bastin, Transfer Pricing and the WTO Pablo Zapatero Miguel, Trade in Generics v. [read post]
27 Jan 2012, 5:00 am
., Inc. v. [read post]
10 Oct 2015, 5:46 am
It made no sense to the court that the shareholder would sell his shares in reliance on statements about himself that he knew were false (Salvani v. [read post]
3 Jul 2013, 5:16 am
State v. [read post]
16 Sep 2016, 9:23 am
Price Waterhouse v. [read post]
10 May 2012, 7:15 am
Williamson v. [read post]
4 Sep 2020, 10:21 am
” Other Claims The state dilution claim survived because Adler alleged enough in-state fame. [read post]
9 Jan 2009, 10:33 am
Hardwick and Lawrence v. [read post]
10 Oct 2011, 8:58 am
In Stephans v. [read post]
10 May 2012, 2:58 am
See Guido v. [read post]
8 Jun 2023, 7:43 am
This first post will discuss the overall biopharmaceutical market and the FTC’s stated theory of harm. [read post]
